Literature DB >> 13459459

Phenylketonuria with normal intelligence and Gowers' muscular dystrophy.

S COATES, A P NORMAN, L I WOOLF.   

Abstract

Entities:  

Keywords:  PHENYLALANINE/in urine; PROGRESSIVE MUSCULAR DYSTROPHY/case reports

Mesh：

Substances：

Year:  1957        PMID： 13459459      PMCID： PMC2012131          DOI： 10.1136/adc.32.164.313

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  18 in total

1.  Treatment of phenylketonuria with a diet low in phenylalanine.

Authors:  L I WOOLF; R GRIFFITHS; A MONCRIEFF
Journal:  Br Med J       Date:  1955-01-08

2.  A possible mechanism for disturbance in tyrosine metabolism in phenylpyruvic oligophrenia.

Authors:  J DANCIS; M E BALIS
Journal:  Pediatrics       Date:  1955-01       Impact factor: 7.124

3.  Influence of phenylalanine intake on phenylketonuria.

Authors:  H BICKEL; J GERRARD; E M HICKMANS
Journal:  Lancet       Date:  1953-10-17       Impact factor: 79.321

4.  The hydroxylation of phenylalanine and antipyrine in phenylpyruvic oligophrenia.

Authors:  S UDENFRIEND; S P BESSMAN
Journal:  J Biol Chem       Date:  1953-08       Impact factor: 5.157

5.  On the excretion of indole derivatives in phenylketonuria.

Authors:  M D ARMSTRONG; K S ROBINSON
Journal:  Arch Biochem Biophys       Date:  1954-09       Impact factor: 4.013

6.  Phenylketonuria with a study of the effect upon it of glutamic acid.

Authors:  L I WOOLF; D G VULLIAMY
Journal:  Arch Dis Child       Date:  1951-12       Impact factor: 3.791

7.  Measurement of pleiotropic effects in phenylketonuria.

Authors:  L S PENROSE
Journal:  Ann Eugen       Date:  1951-09

8.  Estimation of phenylpyruvic acid.

Authors:  J P BERRY; L I WOOLF
Journal:  Nature       Date:  1952-02-02       Impact factor: 49.962

9.  An atypical case of phenylketonuria.

Authors:  V A COWIE
Journal:  Lancet       Date:  1951-02-03       Impact factor: 79.321

10.  Ascorbic acid in aromatic hydroxylation. II. Products formed by reaction of substrates with ascorbic acid, ferrous ion, and oxygen.

Authors:  B B BRODIE; J AXELROD; P A SHORE; S UDENFRIEND
Journal:  J Biol Chem       Date:  1954-06       Impact factor: 5.157
View more
  13 in total

1.  Results of treatment in phenylketonuria.

Authors:  S COATES
Journal:  Br Med J       Date:  1961-03-18

2.  Observations on phenylketonuria in Ontario.

Authors:  M W PARTINGTON
Journal:  Can Med Assoc J       Date:  1961-05-06       Impact factor: 8.262

3.  Discussion on some clinical, genetic and biochemical aspects of metabolic disorders of the nervous system: metabolic disease of the nervous system: clinical aspects.

Authors:  W B MATTHEWS
Journal:  Proc R Soc Med       Date:  1958-10

4.  Some aetiological problems in mental deficiency.

Authors:  J M BERG; B H KIRMAN
Journal:  Br Med J       Date:  1959-10-31

5.  The dietary treatment of phenylketonuria.

Authors:  L I WOOLF; R GRIFFITHS; A MONCRIEFF; S COATES; F DILLISTONE
Journal:  Arch Dis Child       Date:  1958-02       Impact factor: 3.791

6.  Treatment of Phenylketonuria.

Authors: 
Journal:  Br Med J       Date:  1963-06-29

7.  Variations in intelligence in phenylktonuria.

Authors:  M W PARTINGTON
Journal:  Can Med Assoc J       Date:  1962-04-21       Impact factor: 8.262

8.  Hypophosphatasia with phenylketonuria.

Authors:  M E Blaskovics; K N Shaw
Journal:  Z Kinderheilkd       Date:  1974

Review 9.  Phenylketonuria and its variations. A review of recent developments.

Authors:  M E Blaskovics; T L Nelson
Journal:  Calif Med       Date:  1971-07

10.  [A case of "classical" phenylketonuria with average intelligence].

Authors:  W Schwenke; A Anke; A Knapp
Journal:  Klin Wochenschr       Date:  1969-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.